Mercer Global Advisors Inc. ADV Has $3.88 Million Stake in Cabot Co. (NYSE:CBT)

Mercer Global Advisors Inc. ADV boosted its holdings in Cabot Co. (NYSE:CBT) by 0.4% in the 2nd quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The firm owned 42,185 shares of the specialty chemicals company’s stock after purchasing an additional 162 shares during the quarter. Mercer Global Advisors Inc. ADV owned about 0.08% of Cabot worth $3,876,000 at the end of the most recent quarter.

A number of other hedge funds and other institutional investors have also bought and sold shares of CBT. Banque Cantonale Vaudoise grew its holdings in shares of Cabot by 17.5% during the first quarter. Banque Cantonale Vaudoise now owns 833 shares of the specialty chemicals company’s stock valued at $77,000 after buying an additional 124 shares during the last quarter. Miller Howard Investments Inc. NY lifted its position in Cabot by 4.4% in the 2nd quarter. Miller Howard Investments Inc. NY now owns 3,162 shares of the specialty chemicals company’s stock valued at $291,000 after acquiring an additional 132 shares in the last quarter. Los Angeles Capital Management LLC lifted its position in Cabot by 1.4% in the 1st quarter. Los Angeles Capital Management LLC now owns 10,851 shares of the specialty chemicals company’s stock valued at $1,000,000 after acquiring an additional 145 shares in the last quarter. CWM LLC boosted its stake in Cabot by 60.6% during the 2nd quarter. CWM LLC now owns 416 shares of the specialty chemicals company’s stock valued at $38,000 after purchasing an additional 157 shares during the last quarter. Finally, EverSource Wealth Advisors LLC raised its stake in shares of Cabot by 143.1% in the fourth quarter. EverSource Wealth Advisors LLC now owns 333 shares of the specialty chemicals company’s stock worth $28,000 after purchasing an additional 196 shares during the last quarter. Institutional investors own 93.18% of the company’s stock.

Cabot Stock Performance

Shares of Cabot stock opened at $110.27 on Friday. The business’s fifty day simple moving average is $100.14 and its 200 day simple moving average is $96.61. The company has a current ratio of 2.22, a quick ratio of 1.45 and a debt-to-equity ratio of 0.72. Cabot Co. has a 12 month low of $65.10 and a 12 month high of $111.64. The firm has a market capitalization of $6.09 billion, a P/E ratio of 13.96, a price-to-earnings-growth ratio of 0.94 and a beta of 1.19.

Cabot (NYSE:CBT) last released its earnings results on Monday, August 5th. The specialty chemicals company reported $1.92 EPS for the quarter, topping analysts’ consensus estimates of $1.72 by $0.20. The company had revenue of $1.02 billion for the quarter, compared to analysts’ expectations of $1 billion. Cabot had a return on equity of 26.99% and a net margin of 12.05%. The business’s revenue for the quarter was up 5.0% compared to the same quarter last year. During the same period in the previous year, the business posted $1.42 EPS. As a group, analysts anticipate that Cabot Co. will post 7.07 EPS for the current year.

Cabot Announces Dividend

The business also recently announced a quarterly dividend, which was paid on Friday, September 13th. Stockholders of record on Friday, August 30th were given a dividend of $0.43 per share. This represents a $1.72 dividend on an annualized basis and a dividend yield of 1.56%. The ex-dividend date was Friday, August 30th. Cabot’s dividend payout ratio is currently 21.77%.

Insider Transactions at Cabot

In other Cabot news, CFO Erica Mclaughlin sold 23,274 shares of the firm’s stock in a transaction on Wednesday, August 7th. The stock was sold at an average price of $99.79, for a total value of $2,322,512.46. Following the completion of the sale, the chief financial officer now directly owns 59,814 shares of the company’s stock, valued at $5,968,839.06. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through this link. In other news, CFO Erica Mclaughlin sold 23,274 shares of the business’s stock in a transaction that occurred on Wednesday, August 7th. The shares were sold at an average price of $99.79, for a total value of $2,322,512.46. Following the sale, the chief financial officer now owns 59,814 shares of the company’s stock, valued at $5,968,839.06. The transaction was disclosed in a legal filing with the SEC, which is accessible through the SEC website. Also, EVP Hobart Kalkstein sold 5,457 shares of the company’s stock in a transaction that occurred on Tuesday, August 20th. The shares were sold at an average price of $100.58, for a total transaction of $548,865.06. Following the sale, the executive vice president now owns 61,688 shares in the company, valued at $6,204,579.04. The disclosure for this sale can be found here. Insiders sold a total of 71,939 shares of company stock worth $7,308,812 in the last quarter. Insiders own 3.07% of the company’s stock.

Analysts Set New Price Targets

Several brokerages recently issued reports on CBT. JPMorgan Chase & Co. lifted their target price on Cabot from $95.00 to $105.00 and gave the company a “neutral” rating in a research report on Wednesday, August 7th. UBS Group cut their price objective on shares of Cabot from $103.00 to $98.00 and set a “neutral” rating on the stock in a report on Tuesday, August 6th. Finally, StockNews.com downgraded shares of Cabot from a “strong-buy” rating to a “buy” rating in a report on Monday, June 24th. Three analysts have rated the stock with a hold rating and two have issued a buy rating to the company’s stock. According to MarketBeat, the stock has a consensus rating of “Hold” and an average price target of $101.75.

Cabot Profile

Cabot Corporation operates as a specialty chemicals and performance materials company. The company operates through two segments, Reinforcement Materials and Performance Chemicals. It offers reinforcing carbons that are used in tires as a rubber reinforcing agent and performance additive, as well as in industrial products, such as hoses, belts, extruded profiles, and molded goods; and engineered elastomer composites solutions.